WiseOwl research report out with spec buy up to 8.2c
http://www.analyticamedical.com/downloads/2012/20121220-WiseOwl-Analytica.pdf
Expect revenues in Q3 of 2013 and value the Brazillian deal to be worth $3M per annum.
Would make ALT cashflow positive.
Great news
- Forums
- ASX - By Stock
- ALT
- wiseowl 8.2c valuation
wiseowl 8.2c valuation
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online